LATHA S POLAVARAM

Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology GRAND RAPIDS, MI NPI 1194934802

General Payments — all program years on this page

$5,195.27

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 165
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $417.22 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $347.2315
Education $69.991

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $293.368
2019 $665.9923
2020 $88.515
2021 $1,743.745
2022 $1,161.2062
2023 $825.2546
2024 $417.2216

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087294559 Novartis Pharmaceuticals Corporation $16.09 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087294561 Novartis Pharmaceuticals Corporation $22.62 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091961727 Ipsen Biopharmaceuticals, Inc $28.91 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091961729 Ipsen Biopharmaceuticals, Inc $69.99 11/01/2024 Education Undisputed 01/23/2026 View at CMS
1101783998 E.R. Squibb & Sons, L.L.C. $16.63 05/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104340936 AstraZeneca Pharmaceuticals LP $15.20 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104540004 AstraZeneca Pharmaceuticals LP $30.64 04/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105285320 ABBVIE INC. $28.21 02/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105285324 ABBVIE INC. $17.60 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110759650 Eisai Inc. $27.45 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116541360 GlaxoSmithKline, LLC. $18.41 02/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131395963 ARRAY BIOPHARMA INC $19.29 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131421583 ARRAY BIOPHARMA INC $17.67 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139198384 Amneal Pharmaceuticals LLC $29.33 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144965223 Takeda Pharmaceuticals U.S.A., Inc. $27.66 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152172164 SUN PHARMACEUTICAL INDUSTRIES INC. $31.52 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.